首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1788318

主动脉復苏性血管内球囊阻断术的全球市场

Resuscitative Endovascular Balloon Occlusion of the Aorta

出版日期: 2025年08月12日 | 出版商:

Global Industry Analysts, Inc. | 英文 109 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球復苏性主动脉血管内球囊阻断市场规模将达到 3,720 万美元

2024年，全球主动脉復苏性血管内球囊阻断市场规模估计为1,250万美元，预计到2030年将达到3,720万美元，在2024-2030年的分析期内，复合年增长率为20.0%。心臟麻痹是本报告分析的细分市场之一，预计其复合年增长率为18.3%，到分析期结束时达到2,170万美元。主动脉阻断细分市场在分析期间的复合年增长率估计为23.0%。

美国市场规模估计为 330 万美元，中国市场预计复合年增长率为 19.0%

预计2024年美国主动脉復苏性血管内球囊阻断市场规模将达330万美元。作为世界第二大经济体的中国，预计到2030年市场规模将达到570万美元，在2024-2030年的分析期间内，复合年增长率为19.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率分别为18.1%和17.5%。在欧洲，预计德国的复合年增长率约为14.9%。

全球復苏性主动脉血管内球囊阻断市场—主要趋势与驱动因素摘要

为什么復苏性主动脉血管内球囊阻断术（REBOA）在创伤照护中变得如此受欢迎？

復苏性主动脉血管内球囊阻断术 (REBOA) 已成为一种挽救生命的干预措施，适用于因严重腹部、骨盆或下肢损伤而发生出血性休克的创伤患者。传统上，如果这些病例无法控制出血，通常会立即进行开放性手术。然而，REBOA 提供了一种微创的替代方法，可以暂时控制出血并稳定患者病情，直到进行最终的手术治疗，从而提高存活率。机动车事故、战场伤病和工伤事故造成的创伤发生率不断上升，推动了急诊和军事医学对 REBOA 手术的需求。此外，血管通路技术的进步使此手术更加便捷，从而在创伤中心和院前急救中得到更广泛的应用。

科技创新如何让 REBOA 更有效、更安全？

基于导管的介入和血管内技术的创新显着提高了REBOA手术的有效性和安全性。更小、更细的球囊导管的开发减少了与血管通路相关的併发症，并延长了闭塞时间。此外，即时影像导引和压力监测系统可以更精确地放置和充气球囊，从而最大限度地降低缺血性损伤的风险。具有无线监测功能的自动化REBOA系统也正在研究中，该系统允许临床医生远端调整闭塞程度并优化灌注控制。这些技术进步使REBOA成为更可行、更安全的创伤管理方案，并将其临床应用扩展到传统的急救领域之外。

哪些市场趋势推动了 REBOA 市场的扩张？

对创伤护理基础设施建设的日益重视，推动了REBOA在民用和军用医疗机构中的应用。 REBOA与院前急救服务（包括救护车和航空医疗运输单位）的整合，进一步扩大了其应用范围。此外，医疗机构正在投资REBOA培训项目，旨在使创伤外科医生、急诊科医生和重症加护团队掌握有效执行该手术所需的技能。混合手术室和血管内创伤管理通讯协定的兴起也推动了REBOA在三级医疗中心的广泛应用。此外，旨在降低创伤死亡率的政府资助和研究计划也支持了市场的成长。

REBOA 市场的主要成长动力是什么？

全球REBOA市场的成长动力源于创伤相关死亡人数的增加、血管内球囊封堵技术的进步以及紧急创伤护理基础设施的扩展。微创救生手术的普及，尤其是在军事和民间创伤中心，进一步加速了市场需求。此外，正在进行的临床研究旨在优化REBOA技术并将其应用扩展到产后出血等非创伤性疾病，这正在扩大市场潜力。人工智慧监测系统与机器人辅助血管手术的整合也有望提高REBOA的准确性和安全性，从而进一步推动市场扩张。随着医疗保健系统优先考虑针对创伤患者的快速介入策略，REBOA市场正在彻底改变急诊医学领域，预计将实现显着成长。

部分

最终用途（心臟麻痹、主动脉闭塞、战术性战斗伤患护理）

受访公司范例

Abbott Laboratories
Acandis GmbH
AngioDynamics, Inc.
Asahi Kasei Corporation
Bentley InnoMed GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
BVM Medical Limited
Cardinal Health, Inc.
Cook Medical
Edwards Lifesciences Corporation
Emergency Scientific, LLC
Front Line Medical Technologies
Johnson & Johnson
Lepu Medical Technology
Medtronic plc
Merit Medical Systems, Inc.
Mermaid Medical Group
MicroPort Scientific Corporation
Oscor Inc.

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

The global market for Resuscitative Endovascular Balloon Occlusion of the Aorta estimated at US$12.5 Million in the year 2024, is expected to reach US$37.2 Million by 2030, growing at a CAGR of 20.0% over the analysis period 2024-2030. Cardiac Arrest, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$21.7 Million by the end of the analysis period. Growth in the Aortic Occlusion segment is estimated at 23.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Million While China is Forecast to Grow at 19.0% CAGR

The Resuscitative Endovascular Balloon Occlusion of the Aorta market in the U.S. is estimated at US$3.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.7 Million by the year 2030 trailing a CAGR of 19.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.1% and 17.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.9% CAGR.

Global Resuscitative Endovascular Balloon Occlusion of the Aorta Market - Key Trends & Drivers Summarized

Why Is Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) Gaining Widespread Adoption in Trauma Care?

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) has emerged as a life-saving intervention for trauma patients experiencing hemorrhagic shock due to severe abdominal, pelvic, or lower extremity injuries. Traditionally, uncontrolled bleeding in such cases has been managed through immediate open surgery, but REBOA offers a minimally invasive alternative that improves survival rates by temporarily controlling hemorrhage and stabilizing patients until definitive surgical treatment can be performed. The increasing incidence of traumatic injuries from road accidents, battlefield injuries, and industrial accidents has driven the demand for REBOA procedures in emergency and military medicine. Additionally, advancements in vascular access technology have made the procedure more accessible, increasing its adoption across trauma centers and pre-hospital care settings.

How Are Technological Innovations Enhancing the Efficiency and Safety of REBOA?

Innovations in catheter-based interventions and endovascular technology have significantly improved the efficacy and safety of REBOA procedures. The development of smaller, lower-profile balloon catheters has reduced complications associated with vascular access and prolonged occlusion times. Additionally, real-time imaging guidance and pressure monitoring systems are enabling more precise placement and inflation of the balloon, minimizing the risk of ischemic injury. Automated REBOA systems with wireless monitoring capabilities are also being explored, allowing clinicians to remotely adjust occlusion levels and optimize perfusion control. These technological advancements are making REBOA a more viable and safer option for trauma management, expanding its clinical applications beyond traditional emergency settings.

What Market Trends Are Driving the Expansion of the REBOA Market?

The growing emphasis on improving trauma care infrastructure has led to increased adoption of REBOA in both civilian and military healthcare settings. The integration of REBOA into pre-hospital emergency services, including ambulance and air-medical transport units, is further expanding its reach. Additionally, medical institutions are investing in REBOA training programs to equip trauma surgeons, emergency physicians, and critical care teams with the necessary skills to perform the procedure effectively. The rise of hybrid operating rooms and endovascular trauma management protocols has also facilitated the wider adoption of REBOA in tertiary care centers. Moreover, government funding and research initiatives aimed at reducing mortality from traumatic injuries are supporting the market's growth.

What Are the Key Growth Drivers of the REBOA Market?

The growth in the global REBOA market is driven by increasing trauma-related fatalities, advancements in endovascular balloon occlusion technology, and the expansion of emergency trauma care infrastructure. The adoption of minimally invasive life-saving procedures, particularly in military and civilian trauma centers, has further accelerated demand. Additionally, ongoing clinical research into optimizing REBOA techniques and expanding its applications in non-trauma conditions, such as postpartum hemorrhage, is broadening its market potential. The integration of AI-powered monitoring systems and robotic-assisted vascular procedures is also expected to enhance the precision and safety of REBOA, fueling market expansion. As healthcare systems prioritize rapid intervention strategies for trauma patients, the REBOA market is poised for substantial growth, revolutionizing the field of emergency medicine.

SCOPE OF STUDY:

The report analyzes the Resuscitative Endovascular Balloon Occlusion of the Aorta market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Cardiac Arrest, Aortic Occlusion, Tactical Combat Casualty Care)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

Abbott Laboratories
Acandis GmbH
AngioDynamics, Inc.
Asahi Kasei Corporation
Bentley InnoMed GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
BVM Medical Limited
Cardinal Health, Inc.
Cook Medical
Edwards Lifesciences Corporation
Emergency Scientific, LLC
Front Line Medical Technologies
Johnson & Johnson
Lepu Medical Technology
Medtronic plc
Merit Medical Systems, Inc.
Mermaid Medical Group
MicroPort Scientific Corporation
Oscor Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Resuscitative Endovascular Balloon Occlusion of the Aorta - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Incidence of Traumatic Hemorrhage and Non-Compressible Bleeding Conditions Drives REBOA Adoption
- Increased Recognition of REBOA as a Life-Saving Pre-Hospital and Emergency Room Intervention Spurs Clinical Uptake
- Technological Advancements in Balloon Catheter Design Enhance Ease of Deployment and Procedural Speed
- Expansion of Trauma and Acute Care Surgery Programs Throws the Spotlight on Endovascular Resuscitation Devices
- Surge in Combat and Military Applications Strengthens Business Case for REBOA in Battlefield Medicine
- Regulatory Approvals for Low-Profile and Partial Occlusion Devices Expand Indication Spectrum
- Growth in Emergency Medicine Residency Training Supports Familiarity and Usage of REBOA Systems
- Integration of REBOA in Trauma Protocols and ATLS Guidelines Drives Hospital Adoption Rates
- Increased Utilization in Obstetric Hemorrhage and Ruptured Aneurysm Cases Expands Off-Label Applications
- Development of Zone-Specific Occlusion Strategies Enhances Targeted Hemodynamic Stabilization
- Partnerships Between Device Manufacturers and Trauma Centers Accelerate Product Validation and Usage
- Surging Demand for Hemorrhage Control in Civilian Mass Casualty Incidents Fuels Device Availability
- Adoption of Portable and Ultrasound-Guided REBOA Techniques Expands Pre-Hospital Intervention Capabilities
- OEM Investment in Simulation-Based Training Programs Promotes Safe Implementation Across Institutions
- Rising Emphasis on Damage Control Resuscitation Supports Complementary Role of REBOA With Surgical Interventions
- Improved Data From Prospective Trials Strengthens Clinical Confidence and Inclusion in Guidelines
- Use of REBOA in Hybrid Operating Rooms and Angio Suites Increases Workflow Integration
- Focus on Reducing Time-to-Intervention and Transport-Related Mortality Drives REBOA Training Among Paramedics
- Global Expansion of Advanced Trauma Systems Opens Market for REBOA in Developing Countries
- Adoption of Balloon Occlusion Techniques in Non-Traumatic Hemorrhagic Shock Supports Expanded Utility
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Resuscitative Endovascular Balloon Occlusion of the Aorta Market Analysis of Annual Sales in US$ for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
- TABLE 3: World 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Cardiac Arrest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
- TABLE 5: World 6-Year Perspective for Cardiac Arrest by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 6: World Recent Past, Current & Future Analysis for Aortic Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
- TABLE 7: World 6-Year Perspective for Aortic Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Tactical Combat Casualty Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
- TABLE 9: World 6-Year Perspective for Tactical Combat Casualty Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 10: USA Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 11: USA 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
CANADA
- TABLE 12: Canada Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 13: Canada 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
JAPAN
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 14: Japan Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 15: Japan 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
CHINA
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 16: China Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 17: China 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
EUROPE
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 18: Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
- TABLE 19: Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
- TABLE 20: Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 21: Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
FRANCE
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 22: France Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 23: France 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
GERMANY
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 24: Germany Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 25: Germany 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
ITALY
- TABLE 26: Italy Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 27: Italy 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
UNITED KINGDOM
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 28: UK Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 29: UK 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
REST OF EUROPE
- TABLE 30: Rest of Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 31: Rest of Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
ASIA-PACIFIC
- Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 32: Asia-Pacific Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 33: Asia-Pacific 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
REST OF WORLD
- TABLE 34: Rest of World Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 35: Rest of World 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030

IV. COMPETITION

02-2729-4219

+886-2-2729-4219

License/价格

主动脉復苏性血管内球囊阻断术的全球市场